LOCALIZATION OF CLONAL T-CELLS TO THE EPIDERMIS IN CUTANEOUS T-CELL LYMPHOMA

被引:29
作者
FIVENSON, DP [1 ]
HANSON, CA [1 ]
NICKOLOFF, BJ [1 ]
机构
[1] UNIV MICHIGAN,MED CTR,DEPT PATHOL,ANN ARBOR,MI
关键词
D O I
10.1016/S0190-9622(94)70231-4
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Mycosis fungoides (MF) is a form of cutaneous T-cell lymphoma (CTCL) characterized by progression of clonal, epidermotropic T cells with the proliferative (Ki-67(+)) T-cell fraction primarily confined to the epidermis in early CTCL. Objective: Our purpose was to determine whether the malignant clone (recognized by its clonal T-cell receptor [TCR] rearrangement) might also be localized to the epidermal compartment by differential Southern blot analysis. Methods: A rapid heat-saline technique was used to separately isolate epidermal and dermal DNA from 11 patients with CTCL (1 with disease in the pre-MF stage, 4 with patch-stage MF, 3 with plaque-stage MF, 1 with tumor-stage MF, 1 with Sezary syndrome, and 1 with non-MF peripheral T-cell lymphoma). Whole and heat-saline separated 6 mm biopsy specimens (obtained from the same lesion) were analyzed by standard Southern blotting with 5 to 10 mu g of DNA digested with BamHI, HindIII, or EcoRI in each case. Filters were probed with a P-32-labeled TCR-C beta complementary DNA. Skin compartment localization of TCR-C beta rearrangement was compared with results of diagnostic immunophenotyping and expression of proliferating cell nuclear antigen. Results: DNA yields were as follows: from the whole specimens, 14.5 to 62.5 mu g; from epidermal sheets, 2 to 42.5 mu g; and-from the dermis specimens, 2.5 to 25.5 mu g. Whole and separated specimens from one patient with plaque-stage disease, three with patch-stage disease, and one patient with pre-MF disease revealed no rearrangement. Six patients had detectable gene rearrangements in the whole specimen by Southern blot; four of six had identical rearrangements in only the epidermal fragment (including the Sezary syndrome biopsy specimen) and not the dermis. The other two patients had only dermal TCR-C beta rearrangement. No relation was seen between immunophenotype or proliferating cell nuclear antigen expression and the localization of TCR-C beta rearrangements. However, the degree of epidermotropism significantly correlated with the presence of TCR-C beta rearrangements in the epidermal sheets. Conclusion: This study demonstrates that the malignant clone in CTCL can be localized to the epidermal compartment in most cases in which a TCR rearrangement is detectable and that these clones are associated with epidermal proliferation of lymphocytes. This technique of differential epidermal versus dermal Southern analysis for TCR rearrangement may improve sensitivity by helping to distinguish reactive from malignant T-cell populations in future studies of the pathogenesis of CTCL.
引用
收藏
页码:717 / 723
页数:7
相关论文
共 16 条
[1]   INTRAEPIDERMAL LOCALIZATION OF THE CLONE IN CUTANEOUS T-CELL LYMPHOMA [J].
BAGOT, M ;
WECHSLER, J ;
LESCS, MC ;
REVUZ, J ;
FARCET, JP ;
GAULARD, P .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1992, 27 (04) :589-593
[2]   THY-1 AND T-CELL RECEPTOR ANTIGEN EXPRESSION IN MYCOSIS-FUNGOIDES AND BENIGN INFLAMMATORY DERMATOSES [J].
FIVENSON, DP ;
RHEINS, LA ;
NORDLUND, JJ ;
POMARANSKI, M ;
DOUGLASS, MC ;
KRULL, EA .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (15) :1088-1092
[3]   T-CELL RECEPTOR GENE REARRANGEMENT IN CANINE MYCOSIS-FUNGOIDES - FURTHER SUPPORT FOR A CANINE MODEL OF CUTANEOUS T-CELL LYMPHOMA [J].
FIVENSON, DP ;
SAED, GM ;
BECK, ER ;
DUNSTAN, RW ;
MOORE, PF .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (02) :227-230
[4]  
FIVENSON DP, 1992, AM J PATHOL, V141, P1373
[5]   IMMUNODIAGNOSIS IN CUTANEOUS T-CELL LYMPHOMA - HOW DOES GENE-EXPRESSION OF THE VARIABLE REGION OF THE T-CELL RECEPTOR FIT INTO THE DIAGNOSTIC AND PATHOPHYSIOLOGICAL PICTURE OF T-CELL NEOPLASIA [J].
FIVENSON, DP ;
NICKOLOFF, BJ .
JOURNAL OF CUTANEOUS PATHOLOGY, 1992, 19 (01) :1-5
[6]  
FIVENSON DP, BASIC MECHANISMS PHY
[7]  
KNOWLES DM, 1989, AM J PATHOL, V134, P761
[8]  
NICKOLOFF BJ, 1990, AM J PATHOL, V136, P261
[9]  
NICKOLOFF BJ, 1993, J IMMUNOL, V150, P2148
[10]  
NICKOLOFF BJ, 1991, AM J PATHOL, V138, P129